Article
Sanofi sees decision on Zantac dispute with Boehringer in Q1 at earliest
Rating:
0.0
Views:
88
Likes:
1
Library:
1
French drugmaker Sanofi said on Wednesday its dispute with Germany's Boehringer Ingelheim over potential liability for cancer claims in the United States, linked to heartburn drug Zantac, would be decided this quarter at the earliest.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value